I treat & research GU cancers @UTSW in Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Posts=my opinions ASCO COI: https://coi.asco.org/share/3UF-6U3Z/Tian%20Zhanghttps://bsky.app/profile/tiansterzhangmd.bsky.socialhttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3m3fk5i3f222gGlad to be an #ESMOAmbassador during #ESMO25 in Berlin! Here to learn the latest data for our patients and share ideas to improve future outcomes. See you in Berlin! @oncoalert.bsky.social [contains quote post or other embedded content]17 Oct 2025 15:02 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3m3fk5i3f222ghttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lue5eyoklk2v#ShahneenSandhu on collaborative efforts with industry partners - how do we maximize time & effort to make industry supported IITs and large phase 3 trials for clinical development. @anzuptrials.bsky.social #ANZUP2519 Jul 2025 23:45 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lue5eyoklk2vhttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lue4fzbu5s2e@profiand.bsky.social with key insights to large trial and grant funding in Australia — trial impact, equity in diverse populations, cost effectiveness, patient advocate/consumer involvement, and feasibility @anzuptrials.bsky.social #ANZUP2519 Jul 2025 23:28 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lue4fzbu5s2ehttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lue3wrbw722eGreat kickoff to clinical trials workshop #ANZUP25 — #MelissaLeMesurier w patient perspective and #ChrisGianacas biostats on collaborative efforts for clinical trials. Same global themes for clinical trial development. @anzuptrials.bsky.social @craiggedye.bsky.social @profiand.bsky.social19 Jul 2025 23:19 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lue3wrbw722ehttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lue3tup5m22ePleasure to highlight your work with #UroToday @ravimadan.bsky.social - as we all consider how best to treat PSMA avid disease. [contains quote post or other embedded content]19 Jul 2025 23:17 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lue3tup5m22ehttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lsd3dxcu5k23Proud of our #UTSWcancer clinical research teams displaying our cancer center’s ongoing work in clinical trials @aacicancer.bsky.social #CRI25 meeting today! Clinical trials are essential to improving outcomes for our patients with cancer - here to network & learn best practices!24 Jun 2025 02:45 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lsd3dxcu5k23https://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lqpfx2e36c25See our #Urotoday recording with David Wise on this promising trial in #prostatecancer reported at #ASCO25! https://urldefense.com/v3/__https://www.urotoday.com/categories-media/2757-urology-tube-video-channels/asco-2025-vl/4879-phase-i-trial-combines-onc-392-with-lutetium-177-for-prostate-cancer-david-wise.html__;!!MznTZTSvDXGV0Co!FTFsFhhBOPX0Dqfp6X0s2rwSjcPhYRQF91jQNmjtMdeJjj8cqRgLTmr9yZ2bbUvADALqchdggHkb5FzBLpvtWR8VeA$ [contains quote post or other embedded content]03 Jun 2025 13:37 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lqpfx2e36c25https://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lqf64amnas2lTraveling w/ mixed emotions to @asco #asco25 this yr. Celebrating science & the yrs of dedication, work, & patient contributions to cancer clinical trials. But science itself is under attack — defunding of preclinical discovery work will end up slowing our clinical advances. 1/n30 May 2025 11:50 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lqf64amnas2lhttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lpimv2pmqs23Our hearts go out to the Biden family. Metastatic prostate cancer is common but hard. They will face many treatment decisions ahead. https://apple.news/Ai-QLq9onRNWMX8oinuEosA19 May 2025 03:27 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lpimv2pmqs23https://bsky.app/profile/tiansterzhangmd.bsky.social/post/3lnuwwivrgk2gPlenary session with @MarcelaMaus @MGHCancerCenter on future CAR-T cells — setting vision toward personalized, patient centered approaches to find the right CARTs. #AACR25 @oncoalert.bsky.social @theaacr.bsky.social28 Apr 2025 14:08 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3lnuwwivrgk2ghttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3llyx726re22yA great start to #UTChrisWood25 - localized RCC discussions from diagnosis (ccRCC score) & novel tracers to treatment of surgery, SBRT, & ablation. #IvanPedrosa #ChadTang #JoseKaram #IsamuTachibana #mohamedabdelsalam & interactive panel discussion!04 Apr 2025 17:33 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3llyx726re22yhttps://bsky.app/profile/tiansterzhangmd.bsky.social/post/3li5ov5k62c2c@erplimackmd.bsky.social with killer discussion setting the scene for the #NIAGARA “sandwich” & #Checkmate274, both practice changing for our pts w #bladdercancer. @ascocancer.bsky.social #GU2514 Feb 2025 17:07 +0000at://did:plc:mmq2caobcgxv5mmlcomg5fpr/app.bsky.feed.post/3li5ov5k62c2c